UgeneX Therapeutics

Biotechnology Research • Shanghai, 200000, China • 1-10 Employees

Company overview

Headquarters	Shanghai, 200000, China
Website	u-genex.com
NAICS	541714
Keywords	AAV, Ophthalmology, Gene Therapy
Founded	2021
Employees	1-10

Key Contact at UgeneX Therapeutics

Sean Fei

Director of Business Development

About UgeneX Therapeutics

UgeneX is a gene therapy company seeking to bridge pioneering technologies with unmet medical needs in ophthalmology. A unique pipeline focusing on retinal degenerative diseases (RP. AMD and glaucoma) has been established, utilizing the state-of-the-art optogenetics, viral capsid discovery, and protein rational design platforms.

UgeneX Therapeutics revenue & valuation

Annual revenue	$427,775
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$1,400,000
Total funding	No funding

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Director

Funding Data

UgeneX Therapeutics has never raised funding before.